EMA Updates Reexamination Procedure for Pediatric Investigation Plans

Drug Industry Daily
A A
Drugmakers should notify the European Medicines Agency within 10 days of receiving an initial opinion on a pediatric investigation plan if they plan to request another review.

To View This Article:

Login

Subscribe To Drug Industry Daily